The global Post-Traumatic Stress Disorder Therapeutics market was valued at US$ 2410.2 million in 2023 and is anticipated to reach US$ 3135.3 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.

Post-Traumatic Stress Disorder Therapeutics Market

The main treatments for post-traumatic stress disorder (PTSD) are psychological therapies and medication.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Post-Traumatic Stress Disorder Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post-Traumatic Stress Disorder Therapeutics.

Report Scope

The Post-Traumatic Stress Disorder Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Post-Traumatic Stress Disorder Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Post-Traumatic Stress Disorder Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Post-Traumatic Stress Disorder Therapeutics Market Report

Report Metric	Details
Report Name	Post-Traumatic Stress Disorder Therapeutics Market
Accounted market size in 2023	US$ 2410.2 million
Forecasted market size in 2030	US$ 3135.3 million
CAGR	3.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Antidepressants Anti-Anxiety Drugs Others
Segment by Application	Hospitals Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Inc., GlaxoSmithKline plc, Otsuka Pharmaceutical Co., Ltd, Novartis AG, AstraZeneca Plc, Azevan Pharmaceuticals, Inc., Bionomics Ltd., Tonix Pharmaceuticals Holding Corp., Apotex, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Post-Traumatic Stress Disorder Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Post-Traumatic Stress Disorder Therapeutics Market growing?

Ans: The Post-Traumatic Stress Disorder Therapeutics Market witnessing a CAGR of 3.8% during the forecast period 2024-2030.

What is the Post-Traumatic Stress Disorder Therapeutics Market size in 2030?

Ans: The Post-Traumatic Stress Disorder Therapeutics Market size in 2030 will be US$ 3135.3 million.

Who are the main players in the Post-Traumatic Stress Disorder Therapeutics Market report?

Ans: The main players in the Post-Traumatic Stress Disorder Therapeutics Market are Pfizer, Inc., GlaxoSmithKline plc, Otsuka Pharmaceutical Co., Ltd, Novartis AG, AstraZeneca Plc, Azevan Pharmaceuticals, Inc., Bionomics Ltd., Tonix Pharmaceuticals Holding Corp., Apotex, Inc.

What are the Application segmentation covered in the Post-Traumatic Stress Disorder Therapeutics Market report?

Ans: The Applications covered in the Post-Traumatic Stress Disorder Therapeutics Market report are Hospitals, Clinic, Others

What are the Type segmentation covered in the Post-Traumatic Stress Disorder Therapeutics Market report?

Ans: The Types covered in the Post-Traumatic Stress Disorder Therapeutics Market report are Antidepressants, Anti-Anxiety Drugs, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Antidepressants

1.2.3 Anti-Anxiety Drugs

1.2.4 Others

1.3 Market by Application

1.3.1 Global Post-Traumatic Stress Disorder Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinic

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Post-Traumatic Stress Disorder Therapeutics Market Perspective (2019-2030)

2.2 Post-Traumatic Stress Disorder Therapeutics Growth Trends by Region

2.2.1 Global Post-Traumatic Stress Disorder Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Post-Traumatic Stress Disorder Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Post-Traumatic Stress Disorder Therapeutics Market Dynamics

2.3.1 Post-Traumatic Stress Disorder Therapeutics Industry Trends

2.3.2 Post-Traumatic Stress Disorder Therapeutics Market Drivers

2.3.3 Post-Traumatic Stress Disorder Therapeutics Market Challenges

2.3.4 Post-Traumatic Stress Disorder Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Post-Traumatic Stress Disorder Therapeutics Players by Revenue

3.1.1 Global Top Post-Traumatic Stress Disorder Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Post-Traumatic Stress Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Post-Traumatic Stress Disorder Therapeutics Revenue

3.4 Global Post-Traumatic Stress Disorder Therapeutics Market Concentration Ratio

3.4.1 Global Post-Traumatic Stress Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Post-Traumatic Stress Disorder Therapeutics Revenue in 2023

3.5 Post-Traumatic Stress Disorder Therapeutics Key Players Head office and Area Served

3.6 Key Players Post-Traumatic Stress Disorder Therapeutics Product Solution and Service

3.7 Date of Enter into Post-Traumatic Stress Disorder Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Post-Traumatic Stress Disorder Therapeutics Breakdown Data by Type

4.1 Global Post-Traumatic Stress Disorder Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Type (2025-2030)

5 Post-Traumatic Stress Disorder Therapeutics Breakdown Data by Application

5.1 Global Post-Traumatic Stress Disorder Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Post-Traumatic Stress Disorder Therapeutics Market Size (2019-2030)

6.2 North America Post-Traumatic Stress Disorder Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2019-2024)

6.4 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Post-Traumatic Stress Disorder Therapeutics Market Size (2019-2030)

7.2 Europe Post-Traumatic Stress Disorder Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2019-2024)

7.4 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size (2019-2030)

9.2 Latin America Post-Traumatic Stress Disorder Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer, Inc.

11.1.1 Pfizer, Inc. Company Detail

11.1.2 Pfizer, Inc. Business Overview

11.1.3 Pfizer, Inc. Post-Traumatic Stress Disorder Therapeutics Introduction

11.1.4 Pfizer, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

11.1.5 Pfizer, Inc. Recent Development

11.2 GlaxoSmithKline plc

11.2.1 GlaxoSmithKline plc Company Detail

11.2.2 GlaxoSmithKline plc Business Overview

11.2.3 GlaxoSmithKline plc Post-Traumatic Stress Disorder Therapeutics Introduction

11.2.4 GlaxoSmithKline plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

11.2.5 GlaxoSmithKline plc Recent Development

11.3 Otsuka Pharmaceutical Co., Ltd

11.3.1 Otsuka Pharmaceutical Co., Ltd Company Detail

11.3.2 Otsuka Pharmaceutical Co., Ltd Business Overview

11.3.3 Otsuka Pharmaceutical Co., Ltd Post-Traumatic Stress Disorder Therapeutics Introduction

11.3.4 Otsuka Pharmaceutical Co., Ltd Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

11.3.5 Otsuka Pharmaceutical Co., Ltd Recent Development

11.4 Novartis AG

11.4.1 Novartis AG Company Detail

11.4.2 Novartis AG Business Overview

11.4.3 Novartis AG Post-Traumatic Stress Disorder Therapeutics Introduction

11.4.4 Novartis AG Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

11.4.5 Novartis AG Recent Development

11.5 AstraZeneca Plc

11.5.1 AstraZeneca Plc Company Detail

11.5.2 AstraZeneca Plc Business Overview

11.5.3 AstraZeneca Plc Post-Traumatic Stress Disorder Therapeutics Introduction

11.5.4 AstraZeneca Plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

11.5.5 AstraZeneca Plc Recent Development

11.6 Azevan Pharmaceuticals, Inc.

11.6.1 Azevan Pharmaceuticals, Inc. Company Detail

11.6.2 Azevan Pharmaceuticals, Inc. Business Overview

11.6.3 Azevan Pharmaceuticals, Inc. Post-Traumatic Stress Disorder Therapeutics Introduction

11.6.4 Azevan Pharmaceuticals, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

11.6.5 Azevan Pharmaceuticals, Inc. Recent Development

11.7 Bionomics Ltd.

11.7.1 Bionomics Ltd. Company Detail

11.7.2 Bionomics Ltd. Business Overview

11.7.3 Bionomics Ltd. Post-Traumatic Stress Disorder Therapeutics Introduction

11.7.4 Bionomics Ltd. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

11.7.5 Bionomics Ltd. Recent Development

11.8 Tonix Pharmaceuticals Holding Corp.

11.8.1 Tonix Pharmaceuticals Holding Corp. Company Detail

11.8.2 Tonix Pharmaceuticals Holding Corp. Business Overview

11.8.3 Tonix Pharmaceuticals Holding Corp. Post-Traumatic Stress Disorder Therapeutics Introduction

11.8.4 Tonix Pharmaceuticals Holding Corp. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

11.8.5 Tonix Pharmaceuticals Holding Corp. Recent Development

11.9 Apotex, Inc.

11.9.1 Apotex, Inc. Company Detail

11.9.2 Apotex, Inc. Business Overview

11.9.3 Apotex, Inc. Post-Traumatic Stress Disorder Therapeutics Introduction

11.9.4 Apotex, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

11.9.5 Apotex, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Pfizer Inc

GlaxoSmithKline PLC

Otsuka Pharmaceutical Co Ltd

Novartis

Astrazeneca plc

Azevan Pharmaceuticals Inc

Bionomics Ltd

Tonix Pharmaceuticals Holding Corp.

Apotex

List of Tables

Table 1. Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Antidepressants

Table 3. Key Players of Anti-Anxiety Drugs

Table 4. Key Players of Others

Table 5. Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Post-Traumatic Stress Disorder Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Region (2019-2024)

Table 9. Global Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Region (2025-2030)

Table 11. Post-Traumatic Stress Disorder Therapeutics Market Trends

Table 12. Post-Traumatic Stress Disorder Therapeutics Market Drivers

Table 13. Post-Traumatic Stress Disorder Therapeutics Market Challenges

Table 14. Post-Traumatic Stress Disorder Therapeutics Market Restraints

Table 15. Global Post-Traumatic Stress Disorder Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Players (2019-2024)

Table 17. Global Top Post-Traumatic Stress Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder Therapeutics as of 2023)

Table 18. Ranking of Global Top Post-Traumatic Stress Disorder Therapeutics Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Post-Traumatic Stress Disorder Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Post-Traumatic Stress Disorder Therapeutics Product Solution and Service

Table 22. Date of Enter into Post-Traumatic Stress Disorder Therapeutics Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Type (2019-2024)

Table 26. Global Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Type (2025-2030)

Table 28. Global Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Application (2019-2024)

Table 30. Global Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Application (2025-2030)

Table 32. North America Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 47. Pfizer, Inc. Company Detail

Table 48. Pfizer, Inc. Business Overview

Table 49. Pfizer, Inc. Post-Traumatic Stress Disorder Therapeutics Product

Table 50. Pfizer, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 51. Pfizer, Inc. Recent Development

Table 52. GlaxoSmithKline plc Company Detail

Table 53. GlaxoSmithKline plc Business Overview

Table 54. GlaxoSmithKline plc Post-Traumatic Stress Disorder Therapeutics Product

Table 55. GlaxoSmithKline plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 56. GlaxoSmithKline plc Recent Development

Table 57. Otsuka Pharmaceutical Co., Ltd Company Detail

Table 58. Otsuka Pharmaceutical Co., Ltd Business Overview

Table 59. Otsuka Pharmaceutical Co., Ltd Post-Traumatic Stress Disorder Therapeutics Product

Table 60. Otsuka Pharmaceutical Co., Ltd Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 61. Otsuka Pharmaceutical Co., Ltd Recent Development

Table 62. Novartis AG Company Detail

Table 63. Novartis AG Business Overview

Table 64. Novartis AG Post-Traumatic Stress Disorder Therapeutics Product

Table 65. Novartis AG Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 66. Novartis AG Recent Development

Table 67. AstraZeneca Plc Company Detail

Table 68. AstraZeneca Plc Business Overview

Table 69. AstraZeneca Plc Post-Traumatic Stress Disorder Therapeutics Product

Table 70. AstraZeneca Plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 71. AstraZeneca Plc Recent Development

Table 72. Azevan Pharmaceuticals, Inc. Company Detail

Table 73. Azevan Pharmaceuticals, Inc. Business Overview

Table 74. Azevan Pharmaceuticals, Inc. Post-Traumatic Stress Disorder Therapeutics Product

Table 75. Azevan Pharmaceuticals, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 76. Azevan Pharmaceuticals, Inc. Recent Development

Table 77. Bionomics Ltd. Company Detail

Table 78. Bionomics Ltd. Business Overview

Table 79. Bionomics Ltd. Post-Traumatic Stress Disorder Therapeutics Product

Table 80. Bionomics Ltd. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 81. Bionomics Ltd. Recent Development

Table 82. Tonix Pharmaceuticals Holding Corp. Company Detail

Table 83. Tonix Pharmaceuticals Holding Corp. Business Overview

Table 84. Tonix Pharmaceuticals Holding Corp. Post-Traumatic Stress Disorder Therapeutics Product

Table 85. Tonix Pharmaceuticals Holding Corp. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 86. Tonix Pharmaceuticals Holding Corp. Recent Development

Table 87. Apotex, Inc. Company Detail

Table 88. Apotex, Inc. Business Overview

Table 89. Apotex, Inc. Post-Traumatic Stress Disorder Therapeutics Product

Table 90. Apotex, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 91. Apotex, Inc. Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Post-Traumatic Stress Disorder Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Antidepressants Features

Figure 4. Anti-Anxiety Drugs Features

Figure 5. Others Features

Figure 6. Global Post-Traumatic Stress Disorder Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Application: 2023 VS 2030

Figure 8. Hospitals Case Studies

Figure 9. Clinic Case Studies

Figure 10. Others Case Studies

Figure 11. Post-Traumatic Stress Disorder Therapeutics Report Years Considered

Figure 12. Global Post-Traumatic Stress Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Post-Traumatic Stress Disorder Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Region: 2023 VS 2030

Figure 15. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Players in 2023

Figure 16. Global Top Post-Traumatic Stress Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder Therapeutics as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Post-Traumatic Stress Disorder Therapeutics Revenue in 2023

Figure 18. North America Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Post-Traumatic Stress Disorder Therapeutics Market Share by Country (2019-2030)

Figure 20. United States Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Post-Traumatic Stress Disorder Therapeutics Market Share by Country (2019-2030)

Figure 24. Germany Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Share by Region (2019-2030)

Figure 32. China Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Post-Traumatic Stress Disorder Therapeutics Market Share by Country (2019-2030)

Figure 40. Mexico Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Share by Country (2019-2030)

Figure 44. Turkey Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Pfizer, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

Figure 47. GlaxoSmithKline plc Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

Figure 48. Otsuka Pharmaceutical Co., Ltd Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

Figure 49. Novartis AG Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

Figure 50. AstraZeneca Plc Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

Figure 51. Azevan Pharmaceuticals, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

Figure 52. Bionomics Ltd. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

Figure 53. Tonix Pharmaceuticals Holding Corp. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

Figure 54. Apotex, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions